Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433083 | SCV000521222 | likely pathogenic | not provided | 2017-01-23 | criteria provided, single submitter | clinical testing | The M388V variant in the TUBB4A gene has been reported previously in association with hypomyelinating leukodystrophy with atrophy of the basal ganglia and cerebellum (Hamilton et al., 2014; Miyatake et al., 2014). The M388V variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M388V variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in the same residue (M388I, M388T) have also been reported in association with hypomyelinating leukodystrophy with atrophy of the basal ganglia and cerebellum (Hamilton et al., 2014; Posey et al., 2016), supporting the functional importance of this region of the protein. The M388V variant is a strong candidate for a pathogenic variant. |
Revvity Omics, |
RCV000433083 | SCV002021564 | likely pathogenic | not provided | 2019-09-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000258588 | SCV000328478 | not provided | Hypomyelinating leukodystrophy 6 | no assertion provided | literature only |